O-22 - SUSPECTED HCID ASSESSMENT, TESTING AND ISOLATION: EXPLORING A CONUNDRUM
Journal of Public Health · 09.07.2026 · 48 (Supplement_1) · i10-i10
DOI: 10.1093/pubmed/fdag046.019 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Public Health, online erschienen am 09.07.2026. Verfasst von Dr Christopher Redman und 11 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
In the UK key pathogens are classified as High consequence infectious diseases (HCID) - GOV.UK.). Admission of suspected HCID cases to acute settings can significantly disrupt clinical services, despite many patients not requiring hospital care at the time of assessment. Community-based pathways for HCID assessment and sampling vary in availability across Scotland. Remote and rural geography adds further challenges in securing rapid, reliable test results to enable timely standdown or, rarely, escalation of a confirmed case.
Objectives
To reflect on Scotland’s experience in managing suspected and confirmed HCID cases, consider evidence from other UK nations on the impacts of confirmed HCIDs, and describe strengths and challenges identified by multi-agency partners in assessment, sampling and isolation across acute and community settings.
Methods
Literature review of HCID-related impacts on clinical and public health services in the UK (2010–2026); reflection on HCID pathway activations in Scotland; and engagement with multi-agency partners involved in preparedness and response.
Results
Confirmed HCID cases detected in Scotland include H1N1 (2009), CCHF (2012), Ebola virus disease (2014), SARS-CoV-2 (2020) and mpox clade 2 (2022). HCID pathways are also regularly activated for suspected cases, particularly avian influenza and MERS. A community-based approach—maintaining selected patients at home under a multi-agency risk-assessed plan—may offer a more proportionate, patient-centred model. Risk perception and tolerance vary across partner organisations. Strengthened tools, structures and agreements are needed to support consistent multi-agency decision-making and risk management.
Conclusions
Balancing low-likelihood, high-impact risks remains challenging. Clear, streamlined pathways for sampling—whether in emergency departments, wards or at home—are essential, alongside rapid, reliable diagnostics to enable timely de-escalation or, rarely, escalation. A risk-assessed, multiagency community-supported approach may be appropriate but must also consider the transmission risk to the household and community and the need for safe isolation.
Zitieren
APA
Redman, D. C., Stewart, M., Koch, D. O., Moore, P. C., Marsh, D. K., Templeton, D. K., Gunson, P. R., Traherne, M., French, S., Kennedy, D. I., Gibb, C., & Smith, D. K. (2026). O-22 - SUSPECTED HCID ASSESSMENT, TESTING AND ISOLATION: EXPLORING A CONUNDRUM. Journal of Public Health, 48(Supplement_1), i10-i10. https://doi.org/10.1093/pubmed/fdag046.019
Vancouver
Redman DC, Stewart M, Koch DO, Moore PC, Marsh DK, Templeton DK, et al. O-22 - SUSPECTED HCID ASSESSMENT, TESTING AND ISOLATION: EXPLORING A CONUNDRUM. Journal of Public Health. 2026;48(Supplement_1):i10-i10. doi:10.1093/pubmed/fdag046.019
BibTeX
@article{Redman2026,
author = {Redman, Dr Christopher and Stewart, Mary and Koch, Dr Oliver and Moore, Professor Catherine and Marsh, Dr Kim and Templeton, Dr Kate and Gunson, Professor Rory and Traherne, Mark and French, Sophie and Kennedy, Dr Iain and Gibb, Carrie-Anne and Smith, Dr Kate},
title = {O-22 - SUSPECTED HCID ASSESSMENT, TESTING AND ISOLATION: EXPLORING A CONUNDRUM},
journal = {Journal of Public Health},
year = {2026},
volume = {48},
number = {Supplement_1},
pages = {i10--i10},
doi = {10.1093/pubmed/fdag046.019}
}
EUVIMED